Special Milk and Synthetic Biology: A Dual‐Perspective Review of Ingredient Substitutions in Breast‐Milk‐Simulated Infant Formula
Comprehensive Reviews in Food Science and Food Safety · 2026-07 · 25 (4)
DOI: 10.1111/1541-4337.70572 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Comprehensive Reviews in Food Science and Food Safety, online erschienen am 26.07.2026. Verfasst von Chao Zhang und 7 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Food Science and Resource, Nanchang University, Nanchang, China. Hauptthemen laut MEDLINE: Infant Formula, Synthetic Biology, Milk, Human, Milk. Die Arbeit nennt 158 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: National Key R&D Program of China.
Abstract (Originalsprache)
Breast milk (BM) serves as the gold standard for infant nutrition, yet conventional cow's milk‐based infant formulas (IF) fail to adequately replicate its structural and functional complexity. This review critically examines two complementary paradigms, specialty milk utilization and synthetic biology‐enabled precision manufacturing, as transformative strategies for developing biomimetic IF ingredients. Specialty milks, including goat milk, camel milk, donkey milk, buffalo milk, and yak milk, exhibit compositional proximity to BM in specific dimensions, including digestibility, sn‐2 fatty acid profiles, and fat globule size distribution. Synthetic biology platforms have achieved notable industrial‐scale successes, particularly in producing 2′‐fucosyllactose and recombinant lactoferrin. However, significant knowledge gaps persist: the reconstruction of complex multi‐site phosphorylation, the high‐fidelity assembly of triple‐layer milk fat globule membranes, and cost‐effective large‐scale production remain unresolved challenges. Critically, most studies focus on single components rather than integrated formula systems, and robust clinical validation is lacking. This review argues that the convergence of specialty milk matrices with precision‐fermented bioactives represents a paradigm shift from compositional to structure‐function biomimicry. Priority research areas include multi‐omics‐based integration strategies, harmonized regulatory frameworks, and well‐designed clinical trials to establish functional equivalence. Addressing these gaps will be essential for developing next‐generation IF that more closely emulates the functional complexity of BM.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- State Key Laboratory of Food Science and Resource, Nanchang University, Nanchang, China.
- School of Food Science and Technology, Nanchang University, Nanchang, China.
- Jiangxi Province Key Laboratory of Food Allergy, Nanchang, China.
- Sino-German Joint Research Institute, Nanchang University, Nanchang, China.
ORCID-Profile: Yong Wu, Hongbing Chen, Xin Li
Förderung
- National Key R&D Program of China
Zitieren
APA
Zhang, C., Qiu, Y., Mao, Q., Wu, Y., Meng, X., Zheng, S., Chen, H., & Li, X. (2026). Special Milk and Synthetic Biology: A Dual‐Perspective Review of Ingredient Substitutions in Breast‐Milk‐Simulated Infant Formula. Comprehensive Reviews in Food Science and Food Safety, 25(4). https://doi.org/10.1111/1541-4337.70572
Vancouver
Zhang C, Qiu Y, Mao Q, Wu Y, Meng X, Zheng S, et al. Special Milk and Synthetic Biology: A Dual‐Perspective Review of Ingredient Substitutions in Breast‐Milk‐Simulated Infant Formula. Comprehensive Reviews in Food Science and Food Safety. 2026;25(4). doi:10.1111/1541-4337.70572
BibTeX
@article{Zhang2026,
author = {Zhang, Chao and Qiu, Yu and Mao, Qingli and Wu, Yong and Meng, Xuanyi and Zheng, Shuangyan and Chen, Hongbing and Li, Xin},
title = {Special Milk and Synthetic Biology: A Dual‐Perspective Review of Ingredient Substitutions in Breast‐Milk‐Simulated Infant Formula},
journal = {Comprehensive Reviews in Food Science and Food Safety},
year = {2026},
volume = {25},
number = {4},
doi = {10.1111/1541-4337.70572}
}
EUVIMED